Press Releases

Date Title and Summary Additional Formats
Toggle Summary Amphastar Pharmaceuticals Reports Net Revenues of $53.9 Million for the Second Quarter Ended June 30, 2015
RANCHO CUCAMONGA, Calif. , Aug. 12, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the second quarter ended June 30, 2015 . Net revenues of $53.9 million for the second quarter GAAP net loss of $6.6 million , or $0.15
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 12, 2015
RANCHO CUCAMONGA, Calif. , Aug. 4, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2015 ended June 30, 2015 , after the market closes on Wednesday, August 12, 2015 , and will hold a conference call to
View HTML
Toggle Summary Amphastar Pharmaceuticals Receives Approval for AMPHADASE(R) Supplement, Marking the First Product From Its China Facility
RANCHO CUCAMONGA, Calif. , June 22, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") announced today that the U.S. Food and Drug Administration ("FDA") granted approval of the Company's New Drug Application ("NDA") supplement for Amphadase ®
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference 2015
RANCHO CUCAMONGA, Calif. , May 29, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced today that Jason Shandell , President will be presenting at the Jefferies Healthcare Conference on Wednesday, June 3, 2015 at 10:00 a.m. Eastern Time in New York, NY .
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Net Revenues of $56.9 Million for the First Quarter Ended March 31, 2015
RANCHO CUCAMONGA, Calif. , May 13, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") today reported results for the first quarter ended March 31, 2015 . Net revenues of $56.9 million for the first quarter GAAP net loss of $0.7 million , or $0.01
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
RANCHO CUCAMONGA, Calif. , May 11, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced today that Jason Shandell , President will be presenting at the Bank of America Merrill Lynch 2015 Health Care Conference on Thursday, May 14, 2015 at 9:20 a.m.
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 13, 2015
RANCHO CUCAMONGA, Calif. , May 7, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its first quarter of 2015 ended March 31, 2015 , after the market closes on Wednesday, May 13, 2015 , and will hold a conference call to
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference
RANCHO CUCAMONGA, Calif., April 14, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced today that Jason Shandell, President will be presenting at the 14 th Annual Needham Healthcare Conference on Wednesday, April 15, 2015 at 12:10 p.m.
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Revenues of $55.9 Million for the Fourth Quarter Ended December 31, 2014
RANCHO CUCAMONGA, Calif., March 24, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") today reported results for the fourth quarter ended December 31, 2014. Net revenues of $55.9 million for the fourth quarter GAAP net loss of $2.5 million, or
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 24, 2015
RANCHO CUCAMONGA, Calif., March 17, 2015 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) announced that the Company will release results for its fourth quarter of 2014 ended December 31, 2014, after the market closes on Tuesday, March 24, 2015, and will hold a conference call to
View HTML

 

Copyright ©2018 Amphastar Pharmaceuticals, Inc.

Privacy      Terms & Conditions

This site is intended for residents of the United States